Paper42909412PubMed
Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights.
Yan S and 5 others. Int J Med Sci, 2026.
Cite this record
ConductScience Library. Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights. Papers, record 42909412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909412
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights.
- Journal
- Int J Med Sci
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-24
Source PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Organoids | Major topic |
| Neoplasms | Major topic |
| Biomimetics | Major topic |
| Humans | |
| Extracellular Matrix | |
| Animals | |
| Models, Biological | |
| Bioprinting | |
| Coculture Techniques |
Source PubMed
References185
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36226506 | Enabling perfusion through multicellular tumor spheroids promoting lumenization in a vascularized cancer model. | Lab Chip | 2022 | https://conductscience.org/library/papers/36226506 | PubMed |
| 2 | 30771534 | ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30771534 | PubMed |
| 3 | 38238471 | Linking cell mechanical memory and cancer metastasis. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38238471 | PubMed |
| 4 | 34106045 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. | Elife | 2021 | https://conductscience.org/library/papers/34106045 | PubMed |
| 5 | 41389968 | Ultrasound-responsive Pickering emulsions enable extracellular matrix disruption for enhanced sonodynamic immunotherapy. | J Control Release | 2026 | https://conductscience.org/library/papers/41389968 | PubMed |
| 6 | 39622151 | Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy. | Transl Oncol | 2025 | https://conductscience.org/library/papers/39622151 | PubMed |
| 7 | 38071145 | Converging bioprinting and organoids to better recapitulate the tumor microenvironment. | Trends Biotechnol | 2024 | https://conductscience.org/library/papers/38071145 | PubMed |
| 8 | 41882003 | Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction. | Nat Commun | 2026 | https://conductscience.org/library/papers/41882003 | PubMed |
| 9 | 31063753 | The Extracellular Matrix Modulates the Metastatic Journey. | Dev Cell | 2019 | https://conductscience.org/library/papers/31063753 | PubMed |
| 10 | 37508373 | Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37508373 | PubMed |
| 11 | 22622799 | Interstitial fluid pressure as an alternate regulator of angiogenesis independent of hypoxia driven HIF-1α in solid tumors. | J Orthop Res | 2012 | https://conductscience.org/library/papers/22622799 | PubMed |
| 12 | 30647431 | Modelling cancer in microfluidic human organs-on-chips. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30647431 | PubMed |
| 13 | 38992411 | Quantitative atlas of collagen hydrogels reveals mesenchymal cancer cell traction adaptation to the matrix nanoarchitecture. | Acta Biomater | 2024 | https://conductscience.org/library/papers/38992411 | PubMed |
| 14 | 33008910 | Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer. | Sci Adv | 2020 | https://conductscience.org/library/papers/33008910 | PubMed |
| 15 | 40324810 | Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma. | Br J Pharmacol | 2025 | https://conductscience.org/library/papers/40324810 | PubMed |
| 16 | 35119068 | The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/35119068 | PubMed |
| 17 | 41141582 | Hydrogel delivering antifibrotic agent and nano-sonosensitizer enhances efficacy of sonodynamic therapy in osteosarcoma treatment. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41141582 | PubMed |
| 18 | 28520521 | Three-Dimensional Cell Cultures in Drug Discovery and Development. | SLAS Discov | 2017 | https://conductscience.org/library/papers/28520521 | PubMed |
| 19 | 39793891 | ECM stiffness regulates lung fibroblast survival through RasGRF1-dependent signaling. | J Biol Chem | 2025 | https://conductscience.org/library/papers/39793891 | PubMed |
| 20 | 39461060 | Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression. | Biomaterials | 2025 | https://conductscience.org/library/papers/39461060 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42909412
GET https://conductscience.org/api/papers/v1/42909412/references?page=2